Surgery Partners (SGRY) has been drawing attention after recent share price weakness, with the stock closing at US$11.80 and showing declines over the past month and past 3 months.

That recent weakness sits within a tougher stretch overall, with a 30 day share price return showing a decline of 24.07% and a year to date share price return showing a decline of 22.67%, while the 1 year total shareholder return is down 51.62%. This points to fading momentum and a market that appears more cautious on risk.

If this healthcare stock’s pullback has you thinking about where else to put fresh capital to work, it could be a useful moment to scan for other healthcare names using our 36 healthcare AI stocks

With Surgery Partners trading at US$11.80, alongside an indicated intrinsic discount of about 72% and analyst targets that sit higher than the current price, is this weakness hinting at a potential opportunity, or is the market already accounting for future growth?

Most Popular Narrative: 53.6% Undervalued

At a last close of $11.80 against a narrative fair value of about $25.45, the current price sits well below what the most followed model suggests. This sets up a valuation story that leans heavily on future earnings and cash flow improvement.

Disciplined execution on M&A and portfolio optimization, including accretive acquisitions and potential asset sales or health system partnerships, should enhance margin expansion, accelerate deleveraging, and improve free cash flow conversion, supporting improvements in net margins and long-term earnings power.

Want to see what is driving that valuation gap? The core of this narrative is how revenue growth, margin shifts and balance sheet moves combine into a single fair value number.

Result: Fair Value of $25.45 (UNDERVALUED)

However, those assumptions could be challenged if rising interest costs continue to pressure cash flows, or if slower acquisitions and facility sales weigh on revenue and margin progress.

Next Steps

With sentiment clearly split between concern and optimism, it makes sense to move quickly and look at the full picture for yourself. You can start with 3 key rewards and 1 important warning sign

Looking for more investment ideas?

If you only stop at one stock, you risk missing other opportunities that fit your style, so broaden your watchlist before the market moves without you.

• Spot potential turnaround stories early by scanning 32 elite penny stocks with strong financials that already show stronger financial foundations than many peers.
• Zero in on quality at a sensible price by reviewing companies in the 54 high quality undervalued stocks, where cash flows and balance sheets do more of the talking.
• Prioritize resilience and peace of mind by checking the 72 resilient stocks with low risk scores for businesses that score well on stability and financial strength.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.